In this Q&A, Konstantin Dmitrievich Penkov, MD, discusses delayed quality-of-life decline with cemiplimab plus chemotherapy ...
Real-world acne treatment adherence spans 6% to 84%, with cost, adverse effects, and slow results driving nonadherence.
A value-based care pilot within Kentucky’s Medicaid program reduced total costs for adults with substance use disorder while ...